Бериате

Бериате is a human coagulation factor VIII product used to control and prevent bleeding in patients with hemophilia A. This intravenous therapy supports blood clotting by replacing missing or deficient factor VIII. Suitable for routine prophylaxis and on-demand treatment of bleeding episodes.

Human coagulation factor VIII, like Бериате, is primarily used to manage hemophilia A, a genetic disorder causing insufficient clotting factor VIII. It helps prevent and treat bleeding episodes by restoring normal clotting function. This therapy is also used for perioperative management to reduce bleeding risk during surgical procedures in affected patients.

When administered, Бериате works by temporarily increasing factor VIII levels in the bloodstream, supporting the natural clotting process. Users may notice reduced frequency or severity of bleeding episodes after consistent use. The product is designed to integrate into the body’s clotting mechanism without introducing foreign substances.

Store Бериате in a cool, dry place away from direct sunlight. Always check the product’s expiration date before use and ensure proper reconstitution as directed. Keep out of reach of children and pets. Discard any unused solution after use according to local guidelines for medical waste disposal.

No known direct drug interactions have been established for Бериате. However, patients should inform their healthcare provider about all medications, supplements, or herbal products they are using. Caution is advised when combining with other therapies that may affect blood clotting or coagulation pathways.